These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 24487286)

  • 1. The P2Y13 receptor regulates phosphate metabolism and FGF-23 secretion with effects on skeletal development.
    Wang N; Robaye B; Gossiel F; Boeynaems JM; Gartland A
    FASEB J; 2014 May; 28(5):2249-59. PubMed ID: 24487286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the P2Y13 receptor in the differentiation of bone marrow stromal cells into osteoblasts and adipocytes.
    Biver G; Wang N; Gartland A; Orriss I; Arnett TR; Boeynaems JM; Robaye B
    Stem Cells; 2013 Dec; 31(12):2747-58. PubMed ID: 23629754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-1 plays an important role in the bone metabolism under physiological conditions.
    Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y
    Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts.
    Masuyama R; Stockmans I; Torrekens S; Van Looveren R; Maes C; Carmeliet P; Bouillon R; Carmeliet G
    J Clin Invest; 2006 Dec; 116(12):3150-9. PubMed ID: 17099775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of the P2X7 nucleotide receptor reveals its regulatory roles in bone formation and resorption.
    Ke HZ; Qi H; Weidema AF; Zhang Q; Panupinthu N; Crawford DT; Grasser WA; Paralkar VM; Li M; Audoly LP; Gabel CA; Jee WS; Dixon SJ; Sims SM; Thompson DD
    Mol Endocrinol; 2003 Jul; 17(7):1356-67. PubMed ID: 12677010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic mice overexpressing secreted frizzled-related proteins (sFRP)4 under the control of serum amyloid P promoter exhibit low bone mass but did not result in disturbed phosphate homeostasis.
    Cho HY; Choi HJ; Sun HJ; Yang JY; An JH; Cho SW; Kim SW; Kim SY; Kim JE; Shin CS
    Bone; 2010 Aug; 47(2):263-71. PubMed ID: 20472109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone phenotypes of P2 receptor knockout mice.
    Orriss I; Syberg S; Wang N; Robaye B; Gartland A; Jorgensen N; Arnett T; Boeynaems JM
    Front Biosci (Schol Ed); 2011 Jun; 3(3):1038-46. PubMed ID: 21622253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disordered osteoclast formation and function in a CD38 (ADP-ribosyl cyclase)-deficient mouse establishes an essential role for CD38 in bone resorption.
    Sun L; Iqbal J; Dolgilevich S; Yuen T; Wu XB; Moonga BS; Adebanjo OA; Bevis PJ; Lund F; Huang CL; Blair HC; Abe E; Zaidi M
    FASEB J; 2003 Mar; 17(3):369-75. PubMed ID: 12631576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic evidence of serum phosphate-independent functions of FGF-23 on bone.
    Sitara D; Kim S; Razzaque MS; Bergwitz C; Taguchi T; Schüler C; Erben RG; Lanske B
    PLoS Genet; 2008 Aug; 4(8):e1000154. PubMed ID: 18688277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced bone turnover in mice lacking the P2Y13 receptor of ADP.
    Wang N; Robaye B; Agrawal A; Skerry TM; Boeynaems JM; Gartland A
    Mol Endocrinol; 2012 Jan; 26(1):142-52. PubMed ID: 22108801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double disruption of α2A- and α2C-adrenoceptors results in sympathetic hyperactivity and high-bone-mass phenotype.
    Fonseca TL; Jorgetti V; Costa CC; Capelo LP; Covarrubias AE; Moulatlet AC; Teixeira MB; Hesse E; Morethson P; Beber EH; Freitas FR; Wang CC; Nonaka KO; Oliveira R; Casarini DE; Zorn TM; Brum PC; Gouveia CH
    J Bone Miner Res; 2011 Mar; 26(3):591-603. PubMed ID: 20814988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The P2Y13 receptor regulates extracellular ATP metabolism and the osteogenic response to mechanical loading.
    Wang N; Rumney RM; Yang L; Robaye B; Boeynaems JM; Skerry TM; Gartland A
    J Bone Miner Res; 2013 Jun; 28(6):1446-56. PubMed ID: 23362109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive regulation of osteogenesis by bile acid through FXR.
    Cho SW; An JH; Park H; Yang JY; Choi HJ; Kim SW; Park YJ; Kim SY; Yim M; Baek WY; Kim JE; Shin CS
    J Bone Miner Res; 2013 Oct; 28(10):2109-21. PubMed ID: 23609136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic low dose tumor necrosis factor-α (TNF) suppresses early bone accrual in young mice by inhibiting osteoblasts without affecting osteoclasts.
    Gilbert LC; Chen H; Lu X; Nanes MS
    Bone; 2013 Sep; 56(1):174-83. PubMed ID: 23756233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo effects of adiponectin on bone.
    Williams GA; Wang Y; Callon KE; Watson M; Lin JM; Lam JB; Costa JL; Orpe A; Broom N; Naot D; Reid IR; Cornish J
    Endocrinology; 2009 Aug; 150(8):3603-10. PubMed ID: 19406946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine A2B receptors play an important role in bone homeostasis.
    Corciulo C; Wilder T; Cronstein BN
    Purinergic Signal; 2016 Sep; 12(3):537-47. PubMed ID: 27289226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted disruption of nuclear factor erythroid-derived 2-like 1 in osteoblasts reduces bone size and bone formation in mice.
    Kim J; Xing W; Wergedal J; Chan JY; Mohan S
    Physiol Genomics; 2010 Jan; 40(2):100-10. PubMed ID: 19887580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport.
    Kolek OI; Hines ER; Jones MD; LeSueur LK; Lipko MA; Kiela PR; Collins JF; Haussler MR; Ghishan FK
    Am J Physiol Gastrointest Liver Physiol; 2005 Dec; 289(6):G1036-42. PubMed ID: 16020653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program.
    Rosen CJ; Ackert-Bicknell CL; Adamo ML; Shultz KL; Rubin J; Donahue LR; Horton LG; Delahunty KM; Beamer WG; Sipos J; Clemmons D; Nelson T; Bouxsein ML; Horowitz M
    Bone; 2004 Nov; 35(5):1046-58. PubMed ID: 15542029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
    Okamoto M; Murai J; Yoshikawa H; Tsumaki N
    J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.